Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

3 results about "Prostate-specific antigen" patented technology

Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK3 gene. PSA is a member of the kallikrein-related peptidase family and is secreted by the epithelial cells of the prostate gland.

An electrochemical aptamer sensor, a preparation method and application thereof, and a prostate specific antigen detection method

The application discloses an electrochemical aptamer sensor and a preparation method and application thereof, and a prostate specific antigen detection method, and successfully develops a reliable electrochemical biological aptamer sensor for super-sensitivity detection of PSA. An aptamer is used as a biological recognition element to specifically recognize PSA. Nano-porous gold (NP-Gold) with high specific surface area and excellent conductivity is used as a support material. With the help of double-stranded specific nuclease (DSN), noise signals are reduced, the proposed aptamer sensor shows excellent performance in determination of PSA in clinical serum samples, has high sensitivity, strong anti-interference ability and reliable stability. These unique advantages make the aptamer sensor a potential choice for detection of PSA.
Owner:QINGDAO AGRI UNIV

Active compound for treating prostatic cancer and preparation method thereof

The invention belongs to the field of biological medicine, and provides an active compound for treating prostatic cancer and a preparation method thereof. A-B-C-D-P five-module linear connection design is adopted, wherein the A module is a prostate specific membrane antigen targeting binding unit, the B module is a prostate specific antigen enzyme digestion recognition sequence HSSKLQ, the C module is a cathepsin B-responsive Val-Cit-p-aminobenzyl self-destruction unit, the D module is a reduction-responsive disulfide bond connecting arm, and the P is an anti-tumor pharmacodynamic fragment. A coupling reaction is accurately controlled through a continuous flow microchannel technology, controllable self-assembly of the 20-60-nanometer nano aggregate is achieved, the average hydration diameter dispersion coefficient is not larger than 0.20, and the nano aggregate stably exists in plasma and selectively releases drugs in a tumor microenvironment. Multiple contradictions among prodrug system process manufacturability, intracellular response release and stable dispersion of the preparation are solved, and wide clinical application value is achieved.
Owner:NANJING COMTRUE MEDICAL TECH CO LTD

Anti-PSA monoclonal antibody as well as preparation method and application thereof

The invention discloses a separated antibody or antigen binding fragment specifically bound with PSA, the antibody has high detection sensitivity to PSA, the affinity can reach 2.9 * 10 <-9 > M, and a variable region sequence of the antibody is further obtained through sequencing. The antibody can be used for preparing a detection reagent of a prostate specific antigen, is further used for detecting and diagnosing prostate cancer, and has a good application prospect.
Owner:TAIAN FIRST PEOPLES HOSPITAL